Last week, FemmeHealth Alliance hosted our first webinar of 2026: Women’s Hormonal Health — Why Investors Are Paying Attention. Moderated by Stella Ekogbulu, the session brought together investors and ecosystem builders across time zones to explore what is shifting beneath the headlines and what that shift means for capital allocation in women’s health.
A recent milestone helped set the context: Midi Health’s reported $1 billion valuation. The panel agreed the headline matters as a signal, a visible marker that women’s hormonal health is moving from “niche” to economically material, with business models that can scale. We were joined by:
-
Julia Monfrini-Peev, Founder & Managing Partner, PACE Healthcare Capital (early-stage healthcare investing; investor in Alloy Health)
-
Dr. Afua Basoah, Founder, Fern Capital (women’s health VC investing across the UK, Europe, and Africa)
-
Maryann Selfe, Founder, FemmeHealth Alliance and global wealth and investment strategist focused on healthcare, longevity, and portfolio construction
Three themes stood out:
-
Women’s hormonal health is being repriced not invented. Demand is visible, persistent, and increasingly paid for directly by consumers and employers.
-
“Women’s health” is not one risk bucket. The panel emphasized segmentation: a menopause care platform has a fundamentally different risk profile from diagnostics, devices, or therapeutics and underwriting improves when investors stop averaging risk upward.
-
The next bottleneck is growth capital. Early-stage momentum is building, but the ecosystem still needs later-stage capital and aligned stakeholders to move companies from promising traction to scaled outcomes.
Member access: The full recording (including audience Q&A) is available in the FemmeHealth Alliance members’ library.
If you are an investor, founder, clinician, or partner working at the intersection of women’s health and capital, we invite you to join FemmeHealth Alliance. Membership includes access to private webinars, curated convenings, deal-flow visibility, and our on-demand research and recordings library.